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Background: There is limited comparison of clinical follow-up data after single drug-eluting stent implantation with final kissing inflation (FKI) for 
bifurcation lesions according to clinical presentation.
Methods: From the prospective randomized study of SINGLE KISS trial to assess the efficacy of single stent strategy with FKI using by sirolimus- 
(SES) and paclitaxel-eluting stents (PES) for 824 bifurcation lesions, one-year clinical outcomes after those stents implantation were evaluated in 
215 acute coronary syndrome (ACS) and 609 stable angina pectoris (SAP) patients.
Results: The Major Adverse Cardiac Events (MACE) rates between two stent groups were similar (Table). However, in SES group, MACE rates in ACS 
patients were significantly higher than SAP patients.
Conclusions: Single stent strategy with FKI using by SES and PES were similar and effective in ACS and SAP patients.
